Anti-LAG-3 boosts CD8 T cell effector function
Cell · 2024-08 · 187 (16) · 4144-4146
DOI: 10.1016/j.cell.2024.07.004 ↗Kurz gefasst
Kommentar in der Zeitschrift Cell, 2024-08. Verfasst von Courtney T Kureshi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA; Program in Immunology, Harvard Medical School, Boston, M…. Hauptthemen laut MEDLINE: Lymphocyte Activation Gene 3 Protein, CD8-Positive T-Lymphocytes, Antigens, CD. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
LAG-3 is the third immune checkpoint pathway successfully targeted for cancer therapy. Although ineffective as a monotherapy, combination of LAG-3 and PD-1 blockade improves survival from advanced melanoma. In this issue of Cell, two studies in mice and a human clinical trial provide insights on LAG-3 in immune regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA; Program in Immunology, Harvard Medical School, Boston, MA, USA.
- Program in Immunology, Harvard Medical School, Boston, MA, USA; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
- Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA; Program in Immunology, Harvard Medical School, Boston, MA, USA. Electronic address: stephanie_dougan@dfci.harvard.edu.
Zitieren
APA
Kureshi, C. T., Dougan, M., & Dougan, S. K. (2024). Anti-LAG-3 boosts CD8 T cell effector function. Cell, 187(16), 4144-4146. https://doi.org/10.1016/j.cell.2024.07.004
Vancouver
Kureshi CT, Dougan M, Dougan SK. Anti-LAG-3 boosts CD8 T cell effector function. Cell. 2024;187(16):4144-4146. doi:10.1016/j.cell.2024.07.004
BibTeX
@article{Kureshi2024,
author = {Kureshi, Courtney T and Dougan, Michael and Dougan, Stephanie K},
title = {Anti-LAG-3 boosts CD8 T cell effector function},
journal = {Cell},
year = {2024},
volume = {187},
number = {16},
pages = {4144--4146},
doi = {10.1016/j.cell.2024.07.004}
}
EUVIMED